Loading...
Chemical structure of LHF-535

GC65001

LHF-535

Also known as 2-[4-[(Z)-2-[1-(4-propan-2-yloxyphenyl)benzimidazol-5-yl]ethenyl]phenyl]propan-2-ol

LHF-535 is an antiviral agent extracted from patent WO2013123215A2, Compound 38, has EC50s of ＜1 μM, ＜1 μM, ＜1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively

ChemicalCAS1450929-77-7MW412.52FormulaC27H28N2O2
CAS number
1450929-77-7
Molecular weight
412.52
Formula
C27H28N2O2
Solubility
DMSO ： 96·67 mg/mL (234·34 mM; Need ultrasonic)
InChIKey
DBNZTRPIBJSUIX-WAYWQWQTSA-N
Catalogue number
GC65001
Brand
GLPBIO
Computed properties PubChem CID 71711529 · XLogP 5.8 · TPSA 47.3 Ų · H-bond donors 1
XLogP
5.8
TPSA
47.3 Ų
H-bond donors
1
H-bond acceptors
3
Rotatable bonds
6
Heavy atoms
31

SMILES CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C\C4=CC=C(C=C4)C(C)(C)O

Computed descriptors from PubChem (CID 71711529), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.